Executive Director, Theranostics Platform Enablement

The Executive Director, Theranostics Platform Enablement shapes and aligns cross-functional strategies to sustain and expand Novartis's leadership in Theranostics, focusing on Radioligand Therapy and future Radioligand Imaging growth. This role collaborates with various teams to address barriers in patient identification, referral flow, and treatment access while leveraging analytics to inform senior leadership decisions. The position involves overseeing significant budgets and leading teams to drive strategic initiatives across the Theranostics ecosystem.